ARVN compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

ARVNArvinas, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

ARVNArvinas, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ARVN 4

PFEPfizercustomer

NVSNovartis Pharmacustomer

—Yale Universityunlistedsupplier

—Bayerunlistedcustomer

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

ARVNArvinas, Inc.

6.54▼−11.86%· post 6.54

Mkt cap$485.9MRevenue$500,000Q3 FY26Revenue$263MFY25

LLYELI Lilly & Co

1,371.32▼−3.29%· post 1,366.94

ClosedNov 5 '26

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 5 '26

ARVNArvinas, Inc.

LLYELI Lilly & Co

6.54▼−11.86%post 6.54

Price

1,371.32▼−3.29%post 1,366.94

$485.9M

Mkt cap

$1.3T

Q3 FY26$500,000

Revenue

$24.4BQ3 FY26

FY25$263M

Revenue

$65.2BFY25

ARVN6.54▼−11.86%vsLLY1,371.32▼−3.29%ClosedNov 5 '26